Antiviral composition comprising a sulfated polysaccharide
US10342820B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 30, 2012 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Sep 14, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for the use of iota- and/or kappa-carrageenan for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus, paramyxovirus, adenovirus and coronavirus. The present invention further provides for the use of fucoidan, in particular of high molecular weight fucoidan, for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus and paramyxovirus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.